Clik here to view.
Dendreon Tumbles on a DB Downgrade and 2 More Heavily Traded Stocks to Follow
Dendreon Corp. (NASDAQ:DNDN): Closing price $2.91 Shares of Dendreon are down almost 10 percent near the Friday close, after analyst Robyn Karnauskas at Deutsche Bank downgraded the stock from Hold to...
View ArticleClik here to view.
4 Healthcare Stock Stories for Midweek Investment Wellness
Dendreon Corp. (NASDAQ:DNDN): Closing price $2.79 On Wednesday morning, analyst Michael Yee at RBC Capital released a note on shares of Dendreon, suggesting his “best and easiest” solution for the...
View ArticleClik here to view.
4 Healthcare Stock Stories for Weekend Investment Wellness
Dendreon Corp. (NASDAQ: DNDN): Closing price $2.99 On Friday, Dendreon announced the presentation of data from clinical studies featuring Provenge (sipuleucel-T), which is its autologous cellular...
View ArticleClik here to view.
Dendreon Jumps on Word It’s Seeking a Suitor and 2 Other Hot Stocks to Watch
Dendreon Corp. (NASDAQ:DNDN): Current price $2.75 Dendreon shares are up by more than 10 percent Monday in high volume after the manufacturer of the prostate-cancer drug Provenge gained the most in...
View ArticleClik here to view.
Analysts: Dendreon Seeks a Buyer and 3 More Research Notes to Look Through
Dendreon Corp. (NASDAQ:DNDN): Maxim upgraded Dendreon to Buy from Hold and raised its price target for the shares to $10 from $3 after Bloomberg reported late Friday that the company is seeking a...
View ArticleClik here to view.
UnitedHealth Unit Tasked with Healthcare.gov, Boeing’s Big Deal, and 3 More...
UnitedHealth Group (NYSE:UNH): The Obama administration said on Friday that it has named a unit of UnitedHealth Group — Quality Software Services – to make repairs to Healthcare.gov, and gave the end...
View ArticleClik here to view.
NeoStem: A Stem Cell Company Worth Watching
One area of medicine that has been talked about for years is stem cells and whether or not using them can be effective in treating life-threatening illnesses. Although the progress has been slow, this...
View ArticleClik here to view.
Dendreon: A Cautionary Tale For Biotech Investors
Although investors have profited handsomely from biotechnology stocks over the past couple of years, Dendreon (NASDAQ:DNDN) shareholders have not been as fortunate. The iShares US Healthcare ETF...
View ArticleClik here to view.
2 Companies With Game-Changing Oncology Platforms
For the past couple of years, the biotechnology industry has been the hottest sector as companies continue to come up with unique, innovative ways to treat unmet medical needs. In particular,...
View ArticleClik here to view.
BlackBerry’s Privatization Rumors, Inside Evercore’s Upgrade of Microsoft,...
BlackBerry (NASDAQ:BBRY): BlackBerry shares are racing over 5 percent as reports surface that CEO Thorsten Heins and the company’s board are considering taking the company private. The move, which...
View Article
